A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin From Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox) Using Focused Ultrasound in Patients With Primary or Secondary Liver Tumours

Trial Profile

A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin From Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox) Using Focused Ultrasound in Patients With Primary or Secondary Liver Tumours

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Doxorubicin liposomal (Primary)
  • Indications Liver metastases
  • Focus Proof of concept; Therapeutic Use
  • Acronyms TARDOX
  • Most Recent Events

    • 02 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 07 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 May 2017.
    • 07 Apr 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top